Innovation
-
BioSapien Begins First-in-Human MediChip Trial for Rectal Cancer at Burjeel
Abu Dhabi startup BioSapien doses first patient in Phase I trial evaluating its biodegradable MediChip implant to deliver localized chemotherapy directly to…
-
First Human Data on ER-100: What the Sinclair-Linked Eye Gene Therapy Actually Showed
Phase 1 trial of OSK gene therapy in three glaucoma patients finds no serious side effects and preliminary visual field improvements at…
-
SIA Report Finds U.S. Chip Supply Chain Leans More on China Than Headquarters Data Shows
WASHINGTON, October 12 — The Semiconductor Industry Association (SIA) has released a new report titled ‘Understanding Dependencies in the U.S. Semiconductor Supply…
-
Altman and Musk Back Amodei’s Call to Pace AI Development as Trump Pushes Back
San Francisco, September 18 — The fight over how fast artificial intelligence should move has turned inward, and the industry is splitting…
-
Model Finds DNA Mutations Alone Could Cap Median Human Lifespan at 146 to 194 Years
WASHINGTON, July 14 — The global race to slow human aging is no longer a fringe scientific pursuit; it is a strategic…
-
Next-Generation CAR T-Cell Therapies Aim at Solid Tumors and Off-the-Shelf Donor Cells
SAN FRANCISCO, July 14 — The next generation of cancer immunotherapy is racing toward a milestone that could change how thousands of…
-
Experimental vaccine protects mice against fentanyl and related opioids in new study
HOUSTON, July 13 — On the ground in the fight against the opioid crisis, researchers at the University of Houston and the…
-
Only 43 Antibiotics in Development as WHO Warns the Pipeline Falls Short
SINGAPORE, July 11 — For communities across Asia, the medicines that treat common infections are something many families take for granted. But…
-
Strengthening Alberta’s Clinical Trial Infrastructure with New Funding
EDMONTON, July 7 — A significant investment in clinical trials is set to transform cancer care in Alberta, with the Alberta Cancer…
-
CAR-T Therapy Eradicates Brain Tumors in Preclinical Study
LONDON, July 1 — A new immunotherapy treatment tested on animals has completely eliminated tumours in the majority of cases, raising hopes…
-
Anixa Biosciences Secures First Korean Patent for Breast Cancer Vaccine
Anixa’s Korean Patent Opens Door to Clinical Trials in Asia SAN JOSE — The patent paperwork is done. Now comes the hard…
-
England Began World’s First Gonorrhoea Vaccination in August 2025; New Trial Questions Benefit
From August, NHS England will roll out a national programme that uses the 4CMenB meningococcal B vaccine to combat gonorrhea, marking the…
-
FDA Approves New Schizophrenia Medication With Unique Mechanism
The U.S. Food and Drug Administration granted approval on September 15, 2024, for a new fixed-dose combination medication designed to treat schizophrenia.…
-
CRISPR Therapeutics Holds the First Approved CRISPR Therapy, but Its Stock Is Stuck
On December 15, 2023, the biotechnology industry is abuzz with the recent regulatory approval of a groundbreaking treatment by CRISPR Therapeutics AG,…
-
Swiss Brain Implant Allows Paralyzed Man to Walk Naturally
On May 24, 2023, researchers in Switzerland announced a significant medical milestone. A man who had been paralyzed regained the ability to…
Most read
-
First Human Data on ER-100: What the Sinclair-Linked Eye Gene Therapy Actually Showed
-
AACR Report Details Rapid Progress in Targeted Cancer Therapies and Survival
-
Study Links High Sugar Intake to 28% Higher Breast Cancer Risk in Korean Women
-
How Dynasty Trusts Preserve Wealth for a Century Using GST Exemptions
-
BMS GPRC5D CAR-T Arlo-cel Shows Deep Responses After BCMA Failure
-
How Major Medical Centers Partner With Tech Firms for Next-Gen Proton Therapy
-
FDA Denies Approval for Summit Therapeutics’ Ivonescimab in Lung Cancer
-
How will the next era of precision thoracic oncology change treatment choices for lung‑cancer patients?
-
FDA Approval Moves Astellas’ Padcev Into Curative Bladder Cancer Setting
-
Missed NHS England cancer‑treatment target threatens bladder‑cancer surgery waiting times
-
Navigating 7% Mortgage Rates: Strategies for Buying a Home Now
-
Workers Can Boost Tax Savings by Maximizing New $3,500 Health FSA Limit for 2027
-
Fidelity’s Shift to Managed Accounts and Private Assets: What It Means for 401(k) Savers
-
How Required Minimum Distributions Work and Strategies to Lower Taxes
-
BMS GPRC5D CAR-T Arlo-cel Shows Deep Responses After BCMA Failure
-
Understanding the FDA’s Accelerated Approval of Iberdomide for Multiple Myeloma
-
Rockefeller’s 2141-V11 Trial Shows Complete Remission in Two Metastatic Cancer Patients
-
Ellie Sullivan: Genetic Testing Refused for a Decade, Then Offered After Her Diagnosis
-
Personalized mRNA Cancer Vaccine Succeeds in First Phase 3 Melanoma Trial
-
Indiana University Study Ties Delayed Colorectal Cancer Treatment to Higher Metastasis Risk
-
Study: People Who Drank More Water With Meals Ate More Food, Not Less
-
Why Mornings Are Hardest With ADHD: Late Body Clocks, Poor Sleep and Dopamine
-
Immunotherapy and Genome-Based Vaccines Put the Immune System to Work Against Disease
-
Geneticist John Hardy Proposed Alzheimer’s Amyloid Hypothesis in 1992















